question_id,question,overlap_count,overlap_rate,total_unique_chunks,multi_chunk_count,trans_chunk_count,multi_only_count,trans_only_count,overlapping_chunks,multi_only_chunks,trans_only_chunks,multi_sources,trans_sources,multi_scores,trans_scores,multi_avg_relevance,trans_avg_relevance,overlapping_avg_relevance,multi_only_avg_relevance,trans_only_avg_relevance,multi_best_chunk_relevance,trans_best_chunk_relevance
Chinese_Q001,什么是胰岛素抵抗，它如何影响葡萄糖进入细胞？,4,0.8,6,5,5,1,1,"["". This is a condition in which your cells don't respond normally to insulin. As a result, your body needs more insulin to help the glucose enter your cells. At first, your body makes more insulin to try to get cells to respond"", "". As a result, your body needs more insulin to help the glucose enter your cells. At first, your body makes more insulin to try to get cells to respond. But over time, your body can't make enough insulin, and your blood glucose levels rise. You are at higher risk of developing type 2 diabetes if you"", ""Summary: Diabetes, also known as diabetes mellitus, is a disease in which yourblood glucose, or blood sugar, levels are too high. Glucose is your body's main source of energy. Your body can make glucose, but it also comes from the food you eat. Insulin is ahormonemade by your pancreas. Insulin helps"", ""Summary: Type 2diabetesis a disease in which your blood glucose, orblood sugar, levels are too high. Glucose is your main source of energy. It comes from the foods you eat. A hormone called insulin helps the glucose get into your cells to give them energy. If you have diabetes, your body doesn't mak""]","[""SUMMARY: What is diabetes?Diabetes, also known as diabetes mellitus, is a disease in which yourblood glucose, or blood sugar, levels are too high. Glucose is your body's main source of energy. Your body can make glucose, but it also comes from the food you eat. Insulin is ahormonemade by your pancre""]","['CLINICAL PHARMACOLOGY: 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action Glipizide primarily lowers blood glucose by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Sulfonylureas bind to the sulfonylurea receptor in the ']","['MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)']","['MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'FDA']","[12.439598083496094, 14.246325492858887, 14.537849426269531, 14.805669784545898, 14.824319839477539]","[13.693395614624023, 16.0972900390625, 17.396387100219727, 17.763641357421875, 18.17795181274414]",0.6837291359901428,0.6767163395881652,0.6930642277002335,0.6463887691497803,0.6113247871398926,0.7512661814689636,0.7512661814689636
Chinese_Q002,家族史如何影响心脏病的风险？,4,0.8,4,5,5,0,0,"['WARNINGS AND CAUTIONS: WARNINGS AND PRECAUTIONS Serious and potentially fatal cardiovascular (CV) thrombotic events, myocardial infarction, and stroke. Patients with known CV disease/risk factors may be at greater risk. ( 5.1 ) Serious gastrointestinal (GI) adverse events which can be fatal. The ris', '. Some of these factors you can change, but others you cannot.Age.Your risk of heart disease goes up as you get older.Sex.Some factors may affect heart disease risk differently inwomenthan in men.Family history and genetics.A family history of early heart disease raises your risk. And research has s', '. For example:African Americans are more likely than Whites to die of heart disease, while Hispanic Americans are less likely to die of itAsian Americans as a group have lower rates of heart disease than other groups, but South Asian Americans have higher ratesYour family history.You have a greater ', '. The risk is higher in:Men age 45 and olderWomen age 55 and olderYour sex.Some risk factors may affect heart disease risk differently inwomenthan in men. For example:Thehormoneestrogen provides women some protection against heart diseaseDiabetesraises the risk of heart disease more in women than in']",[],[],"['MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'FDA', 'FDA']","['MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'FDA', 'FDA']","[10.960875511169434, 12.916487693786621, 14.89472770690918, 14.935872077941895, 14.935872077941895]","[12.295124053955078, 14.210330963134766, 16.723934173583984, 16.864051818847656, 16.864051818847656]",0.5539562821388244,0.5539562821388244,0.5676568001508713,0.0,0.0,0.7013666033744812,0.7013666033744812
Chinese_Q003,吸烟对血压和心脏病风险有何影响？,4,0.8,4,5,5,0,0,"["". It also adds extra calories, which may cause weight gain. Both of those raise your risk of heart disease. It's best not to drink, but if you do:Have no more than 2 drinks per day if you are a man.Have no more than 1 drink per day if you are a woman.Not smoking.Cigarette smokingraises your blood pr"", '. Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction i', '. It may include only the lifestyle changes. These changes, such as heart-healthy eating and exercise, can be very effective. But sometimes the changes do not control or lower your high blood pressure. Then you may need to take medicine. There are different types of blood pressure medicines. Some pe', '. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine besylate. Control of hi']",[],[],"['FDA', 'FDA', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'FDA']","['MedlinePlus (NIH)', 'FDA', 'FDA', 'MedlinePlus (NIH)', 'FDA']","[12.800302505493164, 12.800302505493164, 13.322488784790039, 13.34329605102539, 13.353544235229492]","[14.97050666809082, 15.384407043457031, 15.384407043457031, 15.411216735839844, 15.842145919799805]",0.613607394695282,0.613607394695282,0.613547220826149,0.0,0.0,0.6244848966598511,0.6244848966598511
Chinese_Q004,可以改变的心脏病风险因素有哪些？,2,0.4,6,5,5,1,3,"['. Some of these factors you can change, but others you cannot.Age.Your risk of heart disease goes up as you get older.Sex.Some factors may affect heart disease risk differently inwomenthan in men.Family history and genetics.A family history of early heart disease raises your risk. And research has s', '. The causes of heart disease depend on the type of disease. Some possible causes include lifestyle, genetics, infections, medicines, and other diseases. There are many different factors that can make you more likely to develop heart disease. Some of these factors you can change, but others you cann']","['ADVERSE REACTIONS: ADVERSE REACTIONS Cardiovascular Effects Tachycardia, hypotension, and hypertension have been reported. QT prolongation and/or ventricular arrhythmias have also been reported, in addition to ECG pattern changes compatible with the polymorphous configuration of Torsades de pointes,']","['. Possible treatments may include:Heart-healthy lifestyle changesMedicinesProcedures orsurgeriesCardiac rehabilitationCan heart diseases be prevented?You may be able to lower your risk of certain heart diseases by makingheart-healthy lifestyle changesand managing any other medical conditions you hav', '. 1.1 Prevention of Cardiovascular Disease In adult patients without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as age, smoking, hypertension, low HDL-C, or a family history of early coronary heart disease, atorvastatin calcium tablets a', 'evident coronary heart disease, atorvastatin calcium tablets are indicated to: Reduce the risk of non-fatal myocardial infarction Reduce the risk of fatal and non-fatal stroke Reduce the risk for revascularization procedures Reduce the risk of hospitalization for CHF Reduce the risk of angina 1.2 Hy']","['MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'FDA', 'FDA', 'FDA']","['FDA', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'FDA', 'MedlinePlus (NIH)']","[8.426546096801758, 9.007890701293945, 9.140356063842773, 9.140356063842773, 9.140356063842773]","[11.086050033569336, 11.376628875732422, 11.405427932739258, 12.412532806396484, 12.95605182647705]",0.678284740447998,0.6587027311325073,0.6933599710464478,0.6682345867156982,0.6355979045232137,0.7048232555389404,0.7048232555389404
Chinese_Q005,不同族群之间心脏病发病率有什么差异？,4,0.8,6,5,5,1,1,"['. Some of these factors you can change, but others you cannot.Age.Your risk of heart disease goes up as you get older.Sex.Some factors may affect heart disease risk differently inwomenthan in men.Family history and genetics.A family history of early heart disease raises your risk. And research has s', '. For example:African Americans are more likely than Whites to die of heart disease, while Hispanic Americans are less likely to die of itAsian Americans as a group have lower rates of heart disease than other groups, but South Asian Americans have higher ratesYour family history.You have a greater ', '. The causes of heart disease depend on the type of disease. Some possible causes include lifestyle, genetics, infections, medicines, and other diseases. There are many different factors that can make you more likely to develop heart disease. Some of these factors you can change, but others you cann', ""Summary: Heart disease is a general term that includes many types of heart problems. It's a type of cardiovascular disease, which means heart and blood vessel disease. Heart disease is the leading cause of death in the United States, but there are ways to prevent and manage many types of heart disea""]",['. The subjects included in the study were men aged 35 to 59 with serum cholesterol levels above 265 mg/dL and no previous history of heart disease. It is not clear to what extent these findings can be extrapolated to females and other segments of the hypercholesterolemic population. (See also PRECAU'],['. The risk is higher in:Men age 45 and olderWomen age 55 and olderYour sex.Some risk factors may affect heart disease risk differently inwomenthan in men. For example:Thehormoneestrogen provides women some protection against heart diseaseDiabetesraises the risk of heart disease more in women than in'],"['MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'FDA', 'MedlinePlus (NIH)']","['MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)']","[10.927579879760742, 11.089288711547852, 11.504047393798828, 12.345380783081055, 12.464027404785156]","[13.72163200378418, 15.557518005371094, 18.84073257446289, 19.044151306152344, 19.067821502685547]",0.6051106929779053,0.5961488246917724,0.6031848788261414,0.6128139495849609,0.5680046081542969,0.6419053077697754,0.6419053077697754
Chinese_Q006,酒精摄入对心脏病风险有什么影响？,1,0.2,1,5,5,0,0,"['. ( 5.2 ) Interaction with Alcohol: Increased effects of alcohol have been reported. Instruct patients to reduce the amount of alcohol they consume until they know whether varenicline affects them. ( 5.3 ) Accidental Injury: Accidental injuries (e.g., traffic accidents) have been reported. Instruct ']",[],[],"['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[12.228259086608887, 12.228259086608887, 12.228259086608887, 12.228259086608887, 12.228259086608887]","[15.5501127243042, 15.5501127243042, 15.5501127243042, 15.5501127243042, 15.5501127243042]",0.6046017408370972,0.6046017408370972,0.6046017408370972,0.0,0.0,0.6046017408370972,0.6046017408370972
Chinese_Q007,额外的卡路里对心脏病风险有什么影响？,2,0.4,5,5,5,2,1,"["". It also adds extra calories, which may cause weight gain. Both of those raise your risk of heart disease. It's best not to drink, but if you do:Have no more than 2 drinks per day if you are a man.Have no more than 1 drink per day if you are a woman.Not smoking.Cigarette smokingraises your blood pr"", '. This is mostly because they are linked to other heart disease risk factors, including high blood cholesterol and triglyceride levels, high blood pressure, and diabetes.Controlling your weightcan lower these risks.Eating a healthy diet.Try to limit saturatedfats, foods high insodium(salt), and adde']","["". Metabolic changes may be associated with increased cardiovascular/cerebrovascular risk. Olanzapine's specific metabolic profile is presented below. Hyperglycemia and Diabetes Mellitus Healthcare providers should consider the risks and benefits when prescribing olanzapine to patients with an establ"", 'WARNINGS: WARNINGS SPECIAL WARNING ON INCREASED RISK OF CARDIOVASCULAR MORTALITY The administration of oral hypoglycemic drugs has been reported to be associated with increased cardiovascular mortality as compared to treatment with diet alone or diet plus insulin. This warning is based on the study ']","['. ( 5.5 ) Weight Gain: Potential consequences of weight gain should be considered. Patients should receive regular monitoring of weight. ( 5.5 ) Tardive Dyskinesia: Discontinue if clinically appropriate. ( 5.6 ) Orthostatic Hypotension: Orthostatic hypotension associated with dizziness, tachycardia,']","['MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'FDA', 'FDA', 'FDA']","['MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'FDA', 'FDA', 'FDA']","[10.077254295349121, 11.329329490661621, 11.973100662231445, 12.453858375549316, 12.453858375549316]","[12.535900115966797, 15.243852615356445, 17.57284164428711, 17.57284164428711, 17.57284164428711]",0.6692002177238464,0.5677497982978821,0.718801885843277,0.644713819026947,0.46704840660095215,0.7377328276634216,0.7377328276634216
Chinese_Q008,压力与心脏病有什么关系？,2,0.4,6,5,5,2,2,"['WARNINGS: WARNINGS Hypertension and Angina Cardiac Failure Sympathetic stimulation is a vital component supporting circulatory function in congestive heart failure, and beta blockade carries the potential hazard of further depressing myocardial contractility and precipitating more severe failure. In', '. Extreme stress can be a ""trigger"" for a heart attack. Also, some common ways of coping with stress, such as overeating, heavy drinking, and smoking, are bad for your heart. Some ways to help manage your stress include exercise, listening to music, focusing on something calm or peaceful, and medita']","['SUMMARY: What is blood pressure?Blood pressure is the force of your blood pushing against the walls of your arteries. Each time your heart beats, it pumps blood into the arteries. Your blood pressure is highest when your heart beats, pumping the blood. This is called systolic pressure. When your hea', 'Summary: Blood pressure is the force of your blood pushing against the walls of your arteries. Each time your heart beats, it pumps blood into the arteries. Your blood pressure is highest when your heart beats, pumping the blood. This is called systolic pressure. When your heart is at rest, between ']","['. Sometimeswomenwill have different symptoms then men. For example, they are more likely to feel tired for no reason. The most common cause of heart attacks iscoronary artery disease(CAD). With CAD, there is a buildup of cholesterol and other material, called plaque, on their inner walls or the arte', '. They include the following: General: fatigue, increased appetite, weight loss, heat intolerance, fever, excessive sweating Central nervous system: headache, hyperactivity, nervousness, anxiety, irritability, emotional lability, insomnia Musculoskeletal: tremors, muscle weakness, muscle spasm Cardi']","['MedlinePlus (NIH)', 'FDA', 'FDA', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)']","['MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'FDA', 'FDA', 'FDA']","[9.371034622192383, 12.386022567749023, 12.386022567749023, 12.455081939697266, 12.587952613830566]","[12.917012214660645, 16.17015838623047, 16.323558807373047, 16.323558807373047, 16.648488998413086]",0.6901938676834106,0.623533821105957,0.7096842527389526,0.682140439748764,0.5759607553482056,0.7520485520362854,0.7520485520362854
Chinese_Q009,哪个族群的心脏病发病率比其他族群低？,1,0.2,5,5,5,1,3,"['. For example:African Americans are more likely than Whites to die of heart disease, while Hispanic Americans are less likely to die of itAsian Americans as a group have lower rates of heart disease than other groups, but South Asian Americans have higher ratesYour family history.You have a greater ']","['marketed or adverse experiences occurring in 0.5 to 1 percent of patients with hypertension or heart failure in clinical trials are listed below and, within each category, are in order of decreasing severity']","['. Some of these factors you can change, but others you cannot.Age.Your risk of heart disease goes up as you get older.Sex.Some factors may affect heart disease risk differently inwomenthan in men.Family history and genetics.A family history of early heart disease raises your risk. And research has s', '. The majority of patients in the SOLVD-Prevention trial had a history of ischemic heart disease. A history of myocardial infarction was present in 80 percent of patients, current angina pectoris in 34 percent, and a history of hypertension in 37 percent. No statistically significant mortality effec', ""Summary: Heart disease is a general term that includes many types of heart problems. It's a type of cardiovascular disease, which means heart and blood vessel disease. Heart disease is the leading cause of death in the United States, but there are ways to prevent and manage many types of heart disea""]","['MedlinePlus (NIH)', 'FDA', 'FDA', 'FDA', 'FDA']","['MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'FDA', 'FDA']","[12.913392066955566, 13.199573516845703, 13.199573516845703, 13.199573516845703, 13.199573516845703]","[15.534154891967773, 19.473896026611328, 20.676918029785156, 21.4615535736084, 21.4615535736084]",0.6542274475097656,0.5755537867546081,0.6561064720153809,0.6537576913833618,0.5429041385650635,0.6561064720153809,0.6561064720153809
Chinese_Q010,家族成员心脏病诊断的年龄阈值是多少会增加风险？,4,0.8,4,5,5,0,0,"['. Some of these factors you can change, but others you cannot.Age.Your risk of heart disease goes up as you get older.Sex.Some factors may affect heart disease risk differently inwomenthan in men.Family history and genetics.A family history of early heart disease raises your risk. And research has s', '. For example:African Americans are more likely than Whites to die of heart disease, while Hispanic Americans are less likely to die of itAsian Americans as a group have lower rates of heart disease than other groups, but South Asian Americans have higher ratesYour family history.You have a greater ', '. 5.5 Age-related Considerations The risk for cardiovascular disease and prevalence of risk factors for cardiovascular disease increase with age. Certain conditions, such as smoking and migraine headache without aura, that do not contraindicate COC use in younger females, are contraindications to us', '. The risk is higher in:Men age 45 and olderWomen age 55 and olderYour sex.Some risk factors may affect heart disease risk differently inwomenthan in men. For example:Thehormoneestrogen provides women some protection against heart diseaseDiabetesraises the risk of heart disease more in women than in']",[],[],"['FDA', 'FDA', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)']","['FDA', 'FDA', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)']","[10.250310897827148, 10.250310897827148, 11.219441413879395, 11.289289474487305, 12.493143081665039]","[13.501739501953125, 13.501739501953125, 13.96630859375, 14.302984237670898, 14.490795135498047]",0.620306271314621,0.620306271314621,0.6097505018115044,0.0,0.0,0.6936650276184082,0.6936650276184082
Chinese_Q011,饮酒超过推荐量对心脏病风险有什么影响？,1,0.2,3,5,5,1,1,"["". It also adds extra calories, which may cause weight gain. Both of those raise your risk of heart disease. It's best not to drink, but if you do:Have no more than 2 drinks per day if you are a man.Have no more than 1 drink per day if you are a woman.Not smoking.Cigarette smokingraises your blood pr""]","['. In the majority of the reported cases, patients had pre-existing cardiovascular disease and/or other risk factors. Although smoking is a risk factor for MI and CVA, based on temporal relationship between medication use and events, a contributory role of varenicline cannot be ruled out [see Warning']","['. ( 5.2 ) Interaction with Alcohol: Increased effects of alcohol have been reported. Instruct patients to reduce the amount of alcohol they consume until they know whether varenicline affects them. ( 5.3 ) Accidental Injury: Accidental injuries (e.g., traffic accidents) have been reported. Instruct ']","['MedlinePlus (NIH)', 'FDA', 'FDA', 'FDA', 'FDA']","['MedlinePlus (NIH)', 'FDA', 'FDA', 'FDA', 'FDA']","[10.680373191833496, 12.503473281860352, 12.503473281860352, 12.503473281860352, 12.503473281860352]","[13.24896240234375, 16.08011245727539, 16.08011245727539, 16.08011245727539, 16.08011245727539]",0.6475175023078918,0.5974072575569153,0.6937337517738342,0.6359634399414062,0.5733256340026855,0.6937337517738342,0.6937337517738342
Chinese_Q012,男性和女性减少心脏病风险的饮酒指南是什么？,3,0.6,5,5,5,1,1,"["". It also adds extra calories, which may cause weight gain. Both of those raise your risk of heart disease. It's best not to drink, but if you do:Have no more than 2 drinks per day if you are a man.Have no more than 1 drink per day if you are a woman.Not smoking.Cigarette smokingraises your blood pr"", '. 1.1 Prevention of Cardiovascular Disease In adult patients without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as age, smoking, hypertension, low HDL-C, or a family history of early coronary heart disease, atorvastatin calcium tablets a', '. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine besylate. Control of hi']","['. ( 5.2 ) Interaction with Alcohol: Increased effects of alcohol have been reported. Instruct patients to reduce the amount of alcohol they consume until they know whether varenicline affects them. ( 5.3 ) Accidental Injury: Accidental injuries (e.g., traffic accidents) have been reported. Instruct ']","['evident coronary heart disease, atorvastatin calcium tablets are indicated to: Reduce the risk of non-fatal myocardial infarction Reduce the risk of fatal and non-fatal stroke Reduce the risk for revascularization procedures Reduce the risk of hospitalization for CHF Reduce the risk of angina 1.2 Hy']","['MedlinePlus (NIH)', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'MedlinePlus (NIH)', 'FDA', 'FDA', 'FDA']","[12.881583213806152, 13.081186294555664, 13.830820083618164, 13.830820083618164, 14.293712615966797]","[14.596220016479492, 15.433387756347656, 15.791970252990723, 16.21198081970215, 16.21198081970215]",0.5955276966094971,0.5981181144714356,0.6140674750010172,0.5479849576950073,0.5609370470046997,0.6279537677764893,0.6279537677764893
Chinese_Q013,管理压力如何影响心脏病风险？,2,0.4,2,5,5,0,0,"['. Extreme stress can be a ""trigger"" for a heart attack. Also, some common ways of coping with stress, such as overeating, heavy drinking, and smoking, are bad for your heart. Some ways to help manage your stress include exercise, listening to music, focusing on something calm or peaceful, and medita', 'WARNINGS: WARNINGS Cardiac Failure Sympathetic stimulation is necessary in supporting circulatory function in congestive heart failure, and beta blockade carries the potential hazard of further depressing myocardial contractility and precipitating more severe failure. In patients with acute myocardi']",[],[],"['MedlinePlus (NIH)', 'FDA', 'FDA', 'FDA', 'FDA']","['MedlinePlus (NIH)', 'FDA', 'FDA', 'FDA', 'FDA']","[9.706056594848633, 11.24410629272461, 11.24410629272461, 11.334592819213867, 11.334592819213867]","[9.275323867797852, 14.346925735473633, 14.346925735473633, 14.411624908447266, 14.411624908447266]",0.6660483121871948,0.6660483121871948,0.690623551607132,0.0,0.0,0.7315822839736938,0.7315822839736938
Chinese_Q014,吸烟者降低心脏病风险的建议措施是什么？,3,0.6,5,5,5,1,1,"['. 1.1 Prevention of Cardiovascular Disease In adult patients without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as age, smoking, hypertension, low HDL-C, or a family history of early coronary heart disease, atorvastatin calcium tablets a', '. Possible treatments may include:Heart-healthy lifestyle changesMedicinesProcedures orsurgeriesCardiac rehabilitationCan heart diseases be prevented?You may be able to lower your risk of certain heart diseases by makingheart-healthy lifestyle changesand managing any other medical conditions you hav', '. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine besylate. Control of hi']","["". It also adds extra calories, which may cause weight gain. Both of those raise your risk of heart disease. It's best not to drink, but if you do:Have no more than 2 drinks per day if you are a man.Have no more than 1 drink per day if you are a woman.Not smoking.Cigarette smokingraises your blood pr""]","['. Treatment plans for heart disease depend on the type of heart disease you have, how serious your symptoms are, and what other health conditions you have. Possible treatments may include: You may be able to lower your risk of certain heart diseases by makingheart-healthy lifestyle changesand managi']","['FDA', 'FDA', 'FDA', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)']","['FDA', 'FDA', 'FDA', 'MedlinePlus (NIH)', 'MedlinePlus (NIH)']","[12.332223892211914, 12.332223892211914, 12.521652221679688, 12.87120246887207, 13.063789367675781]","[14.623520851135254, 14.805356979370117, 14.805356979370117, 14.861543655395508, 15.690404891967773]",0.5824232578277588,0.5849325776100158,0.6009468038876852,0.5475172400474548,0.5600638389587402,0.6214187741279602,0.6214187741279602
Chinese_Q015,戒烟对心脏病风险有什么影响？,2,0.4,4,5,5,1,1,"["". It also adds extra calories, which may cause weight gain. Both of those raise your risk of heart disease. It's best not to drink, but if you do:Have no more than 2 drinks per day if you are a man.Have no more than 1 drink per day if you are a woman.Not smoking.Cigarette smokingraises your blood pr"", '. Iclevia is contraindicated in women over 35 years of age who smoke [ see Contraindications (4) ]. Cigarette smoking increases the risk of serious cardiovascular events from COC use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. ']","['. In the majority of the reported cases, patients had pre-existing cardiovascular disease and/or other risk factors. Although smoking is a risk factor for MI and CVA, based on temporal relationship between medication use and events, a contributory role of varenicline cannot be ruled out [see Warning']","['INDICATIONS AND USAGE: Use • reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking']","['MedlinePlus (NIH)', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'MedlinePlus (NIH)', 'FDA', 'FDA']","[11.86104965209961, 12.099237442016602, 12.099237442016602, 12.113377571105957, 12.113377571105957]","[16.08791732788086, 16.08791732788086, 16.474458694458008, 16.790435791015625, 16.790435791015625]",0.6341297507286072,0.6347051739692688,0.6283057034015656,0.636996328830719,0.638434886932373,0.6400446891784668,0.6400446891784668
Chinese_Q016,女性饮酒以降低心脏病风险的指南是什么？,1,0.2,5,5,5,3,1,"['. 1.1 Prevention of Cardiovascular Disease In adult patients without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as age, smoking, hypertension, low HDL-C, or a family history of early coronary heart disease, atorvastatin calcium tablets a']","["". It also adds extra calories, which may cause weight gain. Both of those raise your risk of heart disease. It's best not to drink, but if you do:Have no more than 2 drinks per day if you are a man.Have no more than 1 drink per day if you are a woman.Not smoking.Cigarette smokingraises your blood pr"", '. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine besylate. Control of hi', 'evident coronary heart disease, atorvastatin calcium tablets are indicated to: Reduce the risk of non-fatal myocardial infarction Reduce the risk of fatal and non-fatal stroke Reduce the risk for revascularization procedures Reduce the risk of hospitalization for CHF Reduce the risk of angina 1.2 Hy']","['. ( 5.2 ) Interaction with Alcohol: Increased effects of alcohol have been reported. Instruct patients to reduce the amount of alcohol they consume until they know whether varenicline affects them. ( 5.3 ) Accidental Injury: Accidental injuries (e.g., traffic accidents) have been reported. Instruct ']","['MedlinePlus (NIH)', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[13.613834381103516, 14.208617210388184, 14.560909271240234, 14.560909271240234, 14.973257064819336]","[15.96596622467041, 16.249279022216797, 16.249279022216797, 16.249279022216797, 16.249279022216797]",0.5821332335472107,0.5281718015670777,0.6028066873550415,0.5783379673957825,0.5095130801200867,0.613860547542572,0.6028066873550415
Chinese_Q017,盐酸甲哌卡因用于什么？,0,0.0,5,5,5,2,3,[],"['CLINICAL PHARMACOLOGY: CLINICAL PHARMACOLOGY Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammato', 'CLINICAL PHARMACOLOGY: CLINICAL PHARMACOLOGY Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. They are also used for their potent anti-inflammatory effects in disorders ']","['DESCRIPTION: 1.1 DESCRIPTION 4% Lidocaine Hydrochloride Injection, USP is a sterile, nonpyrogenic solution containing lidocaine hydrochloride, anhydrous 40 mg/mL in water for injection. May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. pH 6.5 (5.0 to 7.0). Lidocaine has cardia', '. Mepivacaine hydrochloride is related chemically and pharmacologically to the amide-type local anesthetics. It contains an amide linkage between the aromatic nucleus and the amino group. Composition of Available Solutions In Water For Injection 1% Single Dose 30 mL Vial mg/mL 1% Multiple Dose 50 mL', 'DESCRIPTION: DESCRIPTION Mepivacaine hydrochloride is 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride and has the following structural formula: The molecular formula is C 15 H 22 N 2 O HCl. It is a white, crystalline odorless powder, soluble in water, but very resistant ']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[8.080413818359375, 8.080413818359375, 8.080413818359375, 8.178486824035645, 8.178486824035645]","[7.481938362121582, 7.821700096130371, 8.760525703430176, 8.760525703430176, 8.760525703430176]",0.6436148881912231,0.4631898641586304,0.0,0.640650600194931,0.4601906140645345,0.6554720401763916,0.5240938663482666
Chinese_Q018,哌替啶盐酸盐的结构式是什么？,0,0.0,5,5,5,3,2,[],"['DESCRIPTION: 11 DESCRIPTION Divalproex sodium is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship and formed during the partial neutralization of valproic acid with 0.5 equivalent of sodium hydroxide. Chemically it is designated as sodium hy', '. Sulfuric acid and, if necessary, sodium hydroxide may be added to adjust pH (4.0 – 5.5). Preservative: benzalkonium chloride 0.004% Trimethoprim sulfate (Structural formula) Polymyxin B Sulfate, the sulfate salt of polymyxin B1 and B2 (Structural formula)', ""DESCRIPTION: DESCRIPTION Levothyroxine Sodium Tablets, USP contain synthetic crystalline L-3,3',5,5'-tetraiodothyronine sodium salt [levothyroxine (T 4 ) sodium]. Synthetic T 4 is identical to that produced in the human thyroid gland. Levothyroxine (T 4 ) sodium has an empirical formula of C 15 H 10""]","['. Hydrochlorothiazide is chemically described as 6-chloro-3,4-dihydro- 2H -1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide. Hydrochlorothiazide is a thiazide diuretic. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 , its molecular weight is 297.73, and its structural formula is Valsartan and hydroc', '. Hydrochlorothiazide is chemically described as 6-chloro-3,4-dihydro-2 H -1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide. Hydrochlorothiazide is a thiazide diuretic. Its molecular formula is C 7 H 8 ClN 3 O 4 S 2 , its molecular weight is 297.73, and its structural formula is Valsartan and hydroc']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[10.25146484375, 10.25146484375, 10.25146484375, 10.973498344421387, 11.837461471557617]","[8.307141304016113, 8.307141304016113, 8.307141304016113, 8.370783805847168, 8.370783805847168]",0.6584195375442505,0.5650469660758972,0.0,0.6433576345443726,0.5645732879638672,0.6810123920440674,0.5669416785240173
Chinese_Q019,血浆蛋白在局部麻醉药作用中的角色是什么？,0,0.0,8,5,5,3,5,[],"['. Approximately 70% of circulating inhibitory activity for HMG-CoA reductase is attributed to active metabolites. In vitro studies suggest the importance of atorvastatin metabolism by cytochrome P450 3A4, consistent with increased plasma concentrations of atorvastatin in humans following co-administ', '. The metabolites are observed in the urine. The primary metabolic pathway is hydroxylation on the indole ring followed by subsequent glucuronide or sulfate conjugation. In vitro metabolism studies have shown that ondansetron is a substrate for human hepatic cytochrome P-450 enzymes, including CYP1A', 'CLINICAL PHARMACOLOGY: 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol. Cholesterol and']","['. It has been shown that hydroxylation and N-demethylation, which are detoxification reactions, play important roles in the metabolism of the anesthetic. Three metabolites of mepivacaine have been identified from human adults: two phenols, which are excreted almost exclusively as their glucuronide c', '. In vitro , etoposide is highly protein bound (97%) to human plasma proteins. An inverse relationship between plasma albumin levels and etoposide renal clearance is found in children. In a study determining the effect of other therapeutic agents on the in vitro binding of carbon-14 labeled etoposid', '. Distribution In vitro tests show that bupropion is 84% bound to human plasma proteins at concentrations up to 200 mcg/mL. The extent of protein binding of the hydroxybupropion metabolite is similar to that for bupropion, whereas the extent of protein binding of the threohydrobupropion metabolite i', '. Fetal/maternal ratios of local anesthetics appear to be inversely related to the degree of plasma protein binding, because only the free, unbound drug is available for placental transfer. Mepivacaine is approximately 75% bound to plasma proteins. The extent of placental transfer is also determined', '. The 1.5% solution will provide extensive and often complete motor block and the 2% concentration of mepivacaine hydrochloride will produce complete sensory and motor block of any nerve group. The duration of anesthesia also varies depending upon the technique and type of block, the concentration, ']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[7.916149139404297, 7.995219707489014, 8.013972282409668, 8.013972282409668, 8.013972282409668]","[13.013503074645996, 13.760980606079102, 14.466968536376953, 14.714784622192383, 14.817608833312988]",0.6017858028411865,0.525361305475235,0.0,0.5864244302113851,0.525361305475235,0.6248278617858887,0.6015586256980896
Chinese_Q020,什么浓度的盐酸甲哌卡因可以提供完全的感觉和运动阻滞？,0,0.0,7,5,5,2,5,[],"['. These reactions are characterized by signs such as urticaria, pruritus, erythema, angioneurotic edema (including laryngeal edema), tachycardia, sneezing, nausea, vomiting, dizziness, syncope, excessive sweating, elevated temperature, and possibly, anaphylactoid-like symptomatology (including sever', '. These effects are less likely to occur with the synthetic derivatives except when used in large doses. However, since fludrocortisone acetate is a potent mineralocorticoid, both the dosage and salt intake should be carefully monitored in order to avoid the development of hypertension, edema or wei']","['. It has been shown that hydroxylation and N-demethylation, which are detoxification reactions, play important roles in the metabolism of the anesthetic. Three metabolites of mepivacaine have been identified from human adults: two phenols, which are excreted almost exclusively as their glucuronide c', '. Mepivacaine hydrochloride is related chemically and pharmacologically to the amide-type local anesthetics. It contains an amide linkage between the aromatic nucleus and the amino group. Composition of Available Solutions In Water For Injection 1% Single Dose 30 mL Vial mg/mL 1% Multiple Dose 50 mL', 'DESCRIPTION: DESCRIPTION Meperidine Hydrochloride Injection, USP is a sterile solution for intramuscular, subcutaneous or slow intravenous use as a narcotic analgesic. Each mL of the DOSETTE vial contains meperidine hydrochloride, either 25 mg, 50 mg, 75 mg or 100 mg in Water for Injection. Buffered', 'DESCRIPTION: DESCRIPTION Mepivacaine hydrochloride is 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride and has the following structural formula: The molecular formula is C 15 H 22 N 2 O HCl. It is a white, crystalline odorless powder, soluble in water, but very resistant ', '. The 1.5% solution will provide extensive and often complete motor block and the 2% concentration of mepivacaine hydrochloride will produce complete sensory and motor block of any nerve group. The duration of anesthesia also varies depending upon the technique and type of block, the concentration, ']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[9.75517463684082, 9.817693710327148, 9.817693710327148, 9.817693710327148, 9.817693710327148]","[8.687241554260254, 9.263751983642578, 9.54532241821289, 9.943599700927734, 10.208456039428711]",0.5033538937568665,0.3907803237438202,0.0,0.5078226327896118,0.3907803237438202,0.5152705311775208,0.4977828562259674
Chinese_Q021,盐酸甲哌卡因提供的麻醉通常能维持手术多长时间？,0,0.0,5,5,5,2,3,[],"['. This relatively prolonged pharmacodynamic action compared to the short pharmacokinetic half-life (1 to 2 hours) reflects the sustained inactivation of the H + , K + ATPase. Table 3: Gastric Acid Parameters: ACIPHEX Delayed-Release Tablets versus Placebo After 7 Days of Once Daily Dosing Parameter ', '. These phenomena appear to be dose-related, increasing in frequency with higher dosages, and subject to great inter-patient variability. After oral administration, dronabinol has an onset of action of approximately 0.5 to 1 hours and peak effect at 2 to 4 hours. Duration of action for psychoactive ']","['. A dilute concentration of epinephrine (1:200,000 or 5 μ g/mL) usually reduces the rate of absorption and plasma concentration of mepivacaine, however, it has been reported that vasoconstrictors do not significantly prolong anesthesia with mepivacaine. Onset of anesthesia with mepivacaine is rapid,', 'INDICATIONS AND USAGE: 1.3 INDICATIONS AND USAGE 4% Lidocaine Hydrochloride Injection, USP is indicated for the production of topical anesthesia of the mucous membranes of the respiratory tract or the genito-urinary tract. It may be injected trans-tracheally to anesthetize the larynx and trachea, an', '. The 1.5% solution will provide extensive and often complete motor block and the 2% concentration of mepivacaine hydrochloride will produce complete sensory and motor block of any nerve group. The duration of anesthesia also varies depending upon the technique and type of block, the concentration, ']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[8.17159366607666, 8.17159366607666, 9.221818923950195, 9.221818923950195, 9.221818923950195]","[7.890002727508545, 9.921041488647461, 11.472929000854492, 11.472929000854492, 11.472929000854492]",0.6492240905761719,0.47982295155525206,0.0,0.6540976166725159,0.5086583991845449,0.6784652471542358,0.5598964691162109
Chinese_Q022,哌替啶盐酸盐注射液的pH范围是多少？,0,0.0,5,5,5,2,3,[],"['. In healthy volunteers administered intravenous lanthanum as the soluble chloride salt (120 µg), renal clearance was less than 2% of total plasma clearance. Drug Interactions FOSRENOL has a low potential for systemic drug-drug interactions because of the very low bioavailability of lanthanum and be', '. The solutions contain 10% (w/v) alcohol,USP, and 8.70 mg of sodium chloride in sterile water. The pH range is 6.9 to 7.9 and is adjusted with sodium hydroxide and/or hydrochloric acid. The sterile solutions are clear and slightly yellow in color. image description']","['. The product is formulated at pH 5.2 and each 30 mL vial contains 300 mg of eculizumab-aeeb, sorbitol (E420) (1500 mg), acetic acid (18.0 mg), polysorbate 80 (3.0 mg) (vegetable origin), edetate disodium (EDTA) (0.6 mg), sodium hydroxide may be added to adjust pH, and Water for Injection, USP.', '. Sertraline hydrochloride is supplied for oral administration as film-coated tablets containing sertraline hydrochloride equivalent to 25, 50 and 100 mg of sertraline and the following inactive ingredients: D&C Yellow #10 (in 25 mg tablet), dibasic calcium phosphate anhydrous, FD&C Blue #1 (in 25 m', '. Palonosetron Hydrochloride Injection is available as a 5 mL single-dose vial. Each 5 mL vial contains: 0.25 mg palonosetron (equivalent to 0.28 mg palonosetron HCl), 207.5 mg mannitol, disodium edetate and citrate buffer in water for intravenous administration. The pH of the solution in the 5 mL v']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[8.61417007446289, 8.61417007446289, 8.61417007446289, 9.168815612792969, 9.168815612792969]","[9.670760154724121, 11.31847095489502, 11.601157188415527, 11.601157188415527, 11.601157188415527]",0.6750150680541992,0.6120471835136414,0.0,0.6803587973117828,0.596687893072764,0.7070774435997009,0.6350861191749573
Chinese_Q023,哌替啶盐酸盐注射液有哪些给药形式？,0,0.0,7,5,5,2,5,[],"['CLINICAL PHARMACOLOGY: CLINICAL PHARMACOLOGY Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammato', 'CLINICAL PHARMACOLOGY: CLINICAL PHARMACOLOGY Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. They are also used for their potent anti-inflammatory effects in disorders ']","['. 2.2 Instructions for Intravenous Administration Palonosetron hydrochloride injection is supplied ready for intravenous administration at a concentration of 0.05 mg per mL (50 mcg per mL). Do not mix palonosetron hydrochloride injection with other drugs. Flush the infusion line with normal saline b', 'CLINICAL PHARMACOLOGY: CLINICAL PHARMACOLOGY Ipratropium Bromide and Albuterol Sulfate Inhalation Solution is a combination of the β \u200b2 -adrenergic bronchodilator, albuterol sulfate, and the anticholinergic bronchodilator, ipratropium bromide. Albuterol sulfate: Mechanism of Action: \u200b The prime acti', '. Sertraline hydrochloride is supplied for oral administration as film-coated tablets containing sertraline hydrochloride equivalent to 25, 50 and 100 mg of sertraline and the following inactive ingredients: D&C Yellow #10 (in 25 mg tablet), dibasic calcium phosphate anhydrous, FD&C Blue #1 (in 25 m', '. Corticosteroids, Analgesics, Antiemetics/Antinauseants, Antispasmodics and Anticholinergic Agents In controlled clinical trials, palonosetron hydrochloride injection has been safely administered with corticosteroids, analgesics, antiemetics/antinauseants, antispasmodics and anticholinergic agents.', 'DESCRIPTION: 11 DESCRIPTION Palonosetron hydrochloride injection contains palonosetron as palonosetron HCl, an antiemetic and antinauseant agent. It is a serotonin-3 (5-HT 3 ) receptor antagonist with a strong binding affinity for this receptor. Chemically, palonosetron hydrochloride is: (3a S )-2-[']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[6.988699436187744, 6.988699436187744, 6.988699436187744, 7.254420280456543, 7.254420280456543]","[9.776174545288086, 9.95988655090332, 10.746856689453125, 10.781657218933105, 11.33420181274414]",0.662853991985321,0.5524148762226104,0.0,0.6630271673202515,0.5524148762226104,0.6638930439949036,0.6069436073303223
Chinese_Q024,哌替啶盐酸盐的熔点是多少？,0,0.0,6,5,5,3,3,[],"['. Sulfuric acid and, if necessary, sodium hydroxide may be added to adjust pH (4.0 – 5.5). Preservative: benzalkonium chloride 0.004% Trimethoprim sulfate (Structural formula) Polymyxin B Sulfate, the sulfate salt of polymyxin B1 and B2 (Structural formula)', '. The solutions contain 10% (w/v) alcohol,USP, and 8.70 mg of sodium chloride in sterile water. The pH range is 6.9 to 7.9 and is adjusted with sodium hydroxide and/or hydrochloric acid. The sterile solutions are clear and slightly yellow in color. image description', '. The tannate salt of pyrilamine has the empirical formula C 93 H 75 N 3 0 47 and MW = 1986.28. Chlor-Tan A 12 is a decongestant antihistamine suspension, which is red/pink in color with a raspberry flavor and odor. Other ingredients: citric acid, FD&C Red #40, D&C Red #33, raspberry flavor, glyceri']","['. Hydrochlorothiazide is chemically described as 6-chloro-3,4-dihydro- 2H -1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide. Hydrochlorothiazide is a thiazide diuretic. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 , its molecular weight is 297.73, and its structural formula is Valsartan and hydroc', '. Hydrochlorothiazide is chemically described as 6-chloro-3,4-dihydro-2 H -1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide. Hydrochlorothiazide is a thiazide diuretic. Its molecular formula is C 7 H 8 ClN 3 O 4 S 2 , its molecular weight is 297.73, and its structural formula is Valsartan and hydroc', 'DESCRIPTION: DESCRIPTION Cyclobenzaprine hydrochloride is a white, crystalline tricyclic amine salt with the empirical formula C20H21N • HCl and a molecular weight of 311.9. It has a melting point of 217°C, and a pKa of 8.47 at 25°C. It is freely soluble in water and alcohol, sparingly soluble in is']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[10.795300483703613, 12.07105827331543, 12.07105827331543, 12.887284278869629, 12.887284278869629]","[13.961738586425781, 14.056344985961914, 14.056344985961914, 14.056344985961914, 14.063486099243164]",0.6226431488990783,0.4951404809951782,0.0,0.6254357298215231,0.500511368115743,0.6463359594345093,0.5123633146286011
Chinese_Q025,盐酸哌替啶的化学成分是什么？,0,0.0,5,5,5,3,2,[],"['DESCRIPTION: 11 DESCRIPTION Divalproex sodium is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship and formed during the partial neutralization of valproic acid with 0.5 equivalent of sodium hydroxide. Chemically it is designated as sodium hy', '. Sulfuric acid and, if necessary, sodium hydroxide may be added to adjust pH (4.0 – 5.5). Preservative: benzalkonium chloride 0.004% Trimethoprim sulfate (Structural formula) Polymyxin B Sulfate, the sulfate salt of polymyxin B1 and B2 (Structural formula)', '. The tannate salt of pyrilamine has the empirical formula C 93 H 75 N 3 0 47 and MW = 1986.28. Chlor-Tan A 12 is a decongestant antihistamine suspension, which is red/pink in color with a raspberry flavor and odor. Other ingredients: citric acid, FD&C Red #40, D&C Red #33, raspberry flavor, glyceri']","['. Hydrochlorothiazide is chemically described as 6-chloro-3,4-dihydro- 2H -1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide. Hydrochlorothiazide is a thiazide diuretic. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 , its molecular weight is 297.73, and its structural formula is Valsartan and hydroc', '. Hydrochlorothiazide is chemically described as 6-chloro-3,4-dihydro-2 H -1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide. Hydrochlorothiazide is a thiazide diuretic. Its molecular formula is C 7 H 8 ClN 3 O 4 S 2 , its molecular weight is 297.73, and its structural formula is Valsartan and hydroc']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[9.363893508911133, 10.68304443359375, 10.68304443359375, 10.81639289855957, 10.81639289855957]","[9.621110916137695, 9.621110916137695, 9.621110916137695, 9.687217712402344, 9.687217712402344]",0.6489389896392822,0.5912109375,0.0,0.6544191837310791,0.5909930169582367,0.6818201541900635,0.5920826196670532
Chinese_Q026,盐酸哌替啶作为麻醉性镇痛药的作用是什么？,0,0.0,5,5,5,2,3,[],"['CLINICAL PHARMACOLOGY: CLINICAL PHARMACOLOGY Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammato', 'CLINICAL PHARMACOLOGY: CLINICAL PHARMACOLOGY Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. They are also used for their potent anti-inflammatory effects in disorders ']","['CLINICAL PHARMACOLOGY: CLINICAL PHARMACOLOGY Hydrocodone is a semisynthetic narcotic analgesic and antitussive with multiple actions qualitatively similar to those of codeine. Most of these involve the central nervous system and smooth muscle. The precise mechanism of action of hydrocodone and other', 'CLINICAL PHARMACOLOGY: 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action Tramadol hydrochloride tablets contain tramadol, an opioid agonist and inhibitor of norepinephrine and serotonin re- uptake. Although the mode of action is not completely understood, the analgesic effect of tramadol is believed', 'CLINICAL PHARMACOLOGY: CLINICAL PHARMACOLOGY Amitriptyline hydrochloride is an antidepressant with sedative effects. Its mechanism of action in man is not known. It is not a monoamine oxidase inhibitor and it does not act primarily by stimulation of the central nervous system. Amitriptyline inhibits']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[8.065496444702148, 8.065496444702148, 8.065496444702148, 8.115697860717773, 8.115697860717773]","[9.16495132446289, 9.304937362670898, 9.304937362670898, 9.713227272033691, 9.713227272033691]",0.648252522945404,0.5460175752639771,0.0,0.6452686786651611,0.5516327023506165,0.6601879000663757,0.5797083377838135
Chinese_Q027,盐酸哌替啶注射液有哪些浓度可用？,0,0.0,7,5,5,2,5,[],"['. These effects are less likely to occur with the synthetic derivatives except when used in large doses. However, since fludrocortisone acetate is a potent mineralocorticoid, both the dosage and salt intake should be carefully monitored in order to avoid the development of hypertension, edema or wei', '. 12.3 Pharmacokinetics Absorption/Bioavailability Equivalent oral doses of divalproex sodium products and valproic acid capsules deliver equivalent quantities of valproate ion systemically. Although the rate of valproate ion absorption may vary with the formulation administered (liquid, solid, or s']","['. Solutions which are discolored or which contain particulate matter should not be administered. Recommended Concentrations and Doses of Mepivacaine Hydrochloride Procedure Concentration Total Dose Comments mL mg Cervical, brachial, intercostal, 1% 5−40 50−400 Pudendal block: one half of total dose ', '. 2.2 Instructions for Intravenous Administration Palonosetron hydrochloride injection is supplied ready for intravenous administration at a concentration of 0.05 mg per mL (50 mcg per mL). Do not mix palonosetron hydrochloride injection with other drugs. Flush the infusion line with normal saline b', '. Sertraline hydrochloride is supplied for oral administration as film-coated tablets containing sertraline hydrochloride equivalent to 25, 50 and 100 mg of sertraline and the following inactive ingredients: D&C Yellow #10 (in 25 mg tablet), dibasic calcium phosphate anhydrous, FD&C Blue #1 (in 25 m', '. Palonosetron Hydrochloride Injection is available as a 5 mL single-dose vial. Each 5 mL vial contains: 0.25 mg palonosetron (equivalent to 0.28 mg palonosetron HCl), 207.5 mg mannitol, disodium edetate and citrate buffer in water for intravenous administration. The pH of the solution in the 5 mL v', '. Each single-dose vial, formulated in an aqueous solution, is available at a concentration of 20 mg/mL containing 80 mg/4 mL, 200 mg/10 mL, or 400 mg/20 mL of TOFIDENCE. Each mL of solution contains arginine hydrochloride (10.53 mg), histidine (0.81 mg), L-histidine hydrochloride monohydrate (1.01 ']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[8.94089126586914, 8.94089126586914, 8.94089126586914, 9.114282608032227, 9.114282608032227]","[9.41240406036377, 10.763940811157227, 11.23800277709961, 12.287792205810547, 12.324584007263184]",0.6652658939361572,0.5878236532211304,0.0,0.6584808826446533,0.5878236532211304,0.6924059391021729,0.5928723812103271
Chinese_Q028,血浆浓度与局部麻醉药物结合之间的关系是什么？,1,0.2,5,5,5,2,2,"['. Fetal/maternal ratios of local anesthetics appear to be inversely related to the degree of plasma protein binding, because only the free, unbound drug is available for placental transfer. Mepivacaine is approximately 75% bound to plasma proteins. The extent of placental transfer is also determined']","['. Bleeding events related to drugs that interfere with serotonin reuptake have ranged from ecchymoses, hematomas, epistaxis, and petechiae to life-threatening hemorrhages. Inform patients about the increased risk of bleeding associated with the concomitant use of paroxetine and antiplatelet agents o', '. At blood concentrations achieved with normal therapeutic doses, changes in cardiac conduction, excitability, refractoriness, contractility, and peripheral vascular resistance are minimal. However, toxic blood concentrations depress cardiac conduction and excitability, which may lead to atrioventri']","['. In the plasma, olanzapine accounted for only 12% of the AUC for total radioactivity, indicating significant exposure to metabolites. After multiple dosing, the major circulating metabolites were the 10-N-glucuronide, present at steady state at 44% of the concentration of olanzapine, and 4′-N-desme', 'DOSAGE AND ADMINISTRATION: DOSAGE AND ADMINISTRATION The dose of any local anesthetic administered varies with the anesthetic procedure, the area to be anesthetized, the vascularity of the tissues, the number of neuronal segments to be blocked, the depth of anesthesia and degree of muscle relaxation']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[8.076412200927734, 8.605328559875488, 8.676178932189941, 8.676178932189941, 8.676178932189941]","[11.223373413085938, 12.357619285583496, 12.423261642456055, 12.423261642456055, 12.423261642456055]",0.6255855798721314,0.6121713280677795,0.6261987686157227,0.6143472790718079,0.5797103941440582,0.6365172863006592,0.6376185417175293
Chinese_Q029,唑来膦酸注射液的潜在肾脏副作用有哪些？,0,0.0,4,5,5,1,3,[],"['. Renal toxicity has also been seen in patients in whom renal prostaglandins have a compensatory role in the maintenance of renal perfusion. In these patients, administration of a nonsteroidal anti-inflammatory drug may cause a dose-dependent reduction in prostaglandin formation and, secondarily, in']","['. The incidence of renal toxicity and renal failure has been shown to be reduced when Zoledronic Acid Injection 4 mg is given as a 15 - minute intravenous infusion. Zoledronic Acid Injection should be administered by intravenous infusion over no less than 15 minutes [ see Warnings and Precautions ( ', '. The following are data on the incidence of renal deterioration in patients receiving Zoledronic Acid Injection 4 mg over 15 minutes in these trials (see Table 9 ). Table 9: Percentage of Patients with Treatment Emergent Renal Function Deterioration by Baseline Serum Creatinine* *Table includes onl', '. In the trials and in postmarketing experience, renal deterioration, progression to renal failure and dialysis have occurred in patients with normal and abnormal baseline renal function, including patients treated with 4 mg infused over a 15 - minute period. There have been instances of this occurr']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[6.429294586181641, 6.429294586181641, 6.558496475219727, 6.558496475219727, 6.558496475219727]","[8.11402702331543, 8.11402702331543, 8.21788215637207, 8.21788215637207, 9.142928123474121]",0.701798677444458,0.6089733600616455,0.0,0.701798677444458,0.6072913606961569,0.701798677444458,0.6640781760215759
Chinese_Q030,在唑来膦酸注射液的上市后使用中报告了哪些不良反应？,0,0.0,7,5,5,5,2,[],"['. 6.2 Postmarketing Experience The following adverse reactions have been identified during postapproval use of indomethacin. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal rela', '. Laboratory Tests: Mild to moderate elevations of ALT, LDH, alkaline phosphatase, BUN and creatinine have been noted. The relationship of these abnormalities to glipizide is uncertain. 6.2 Postmarketing Experience The following adverse reactions have been identified during post approval use of glip', 'ADVERSE REACTIONS: ADVERSE REACTIONS The following adverse reactions have been identified during post-approval use of Hydroxychloroquine sulfate tablets or other 4-aminoqunoline compounds. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible', '. Henoch- Schonlein vasculitis, angioedema RENAL Acute renal failure (see PRECAUTIONS ), decreased creatinine clearance, polyuria, azotemia, cystitis, Hematuria Renal papillary necrosis MISCELLANEOUS Dry eyes and mouth, gingival ulcer, rhinitis Postmarketing Experience The following adverse reaction', '. Metabolic acidosis has also been reported in patients receiving higher doses. Reports of extravasation with swelling have been received postmarketing. Rarely extravasation has been associated with necrosis and venous induration. The incidences of adverse reactions in the table that follows are der']","['ADVERSE REACTIONS: ADVERSE REACTIONS Clinical Trials and Post-marketing Surveillance The adverse reactions listed below reflect the experience from investigational studies of Amnesteem, and the post-marketing experience. The relationship of some of these events to Amnesteem therapy is unknown. Many ', '. 6.2 Postmarketing Experience The following additional adverse reactions have been identified during postmarketing use of gadobutrol injection or other GBCAs. Because these reactions are reported voluntarily from a population of uncertain size, it is not possible to reliably estimate their frequenc']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","['FDA', 'FDA', 'FDA', 'FDA', 'FDA']","[4.990294456481934, 5.535497665405273, 5.537463665008545, 6.054627895355225, 6.171749114990234]","[9.378746032714844, 9.378746032714844, 9.378746032714844, 10.119569778442383, 10.119569778442383]",0.6184826374053956,0.5635105609893799,0.0,0.6184826374053956,0.5496501475572586,0.6833542585372925,0.618952214717865
